Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 28, Issue 6, 2005, Pages 640-641

  Morbidini Gaffney, Stefania ^a   Alpert, Tracy E ^a   Hatoum, Georges F ^a   Sagerman, Robert H ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Hodgkin; Radiation; Schwannoma; Secondary malignancy

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; PROTEIN S 100; THYROTROPIN; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DYSPHAGIA; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; NEURILEMOMA; NODULAR GOITER; PATIENT MONITORING; PHYSICAL EXAMINATION; RADIATION DOSE; SPINDLE CELL CARCINOMA; THORAX PAIN; THORAX WALL CANCER; THYROTROPIN BLOOD LEVEL; TUMOR BIOPSY;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARCINOMA, BASAL CELL; COMBINED MODALITY THERAPY; DACARBAZINE; DOXORUBICIN; FEMALE; GOITER, NODULAR; HODGKIN DISEASE; HUMANS; MECHLORETHAMINE; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; NEURILEMMOMA; PLEURAL NEOPLASMS; PREDNISONE; PROCARBAZINE; RADIOTHERAPY; RECURRENCE; SKIN NEOPLASMS; VINBLASTINE; VINCRISTINE;

EID: 29044435252     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000158490.21506.87     Document Type: Article

References (4)

1. Donaldson SS, Hancock SL, Hoppe RT. The Janeway lecture. Hodgkin's disease-finding the balance between cure and late effects. Cancer J Sci Am. 1999;5:325-333.
2. Hancock SL, Hoppe RT. Long-term complications of treatment and causes of mortality after Hodgkin's disease. Semin Radiat Oncol. 1996;6:225-242.
3. Fisher PM, Dodwell DJ, Bridges LR, et al. Malignant schwannoma following treatment for Hodgkin's disease. Clin Oncol. 1994;6:204-205.
4. Ng AK, Bernardo MV, Weller E, et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood. 2002;100:1989-1996.